As Moderna CEO Stéphane Bancel heads to Capitol Hill to testify before the Health, Education, Labor, and Pensions (HELP) Committee, experts are watching to see …
To protect innovation, we need to protect Bayh-Dole, says one expert Read More »
On Wednesday, Moderna’s CEO will testify before the Senate Health, Education, Labor, and Pensions (HELP) Committee in a hearing with a misleading title, “Taxpayers Paid …
While awaiting for the public hearing on the proposed expansion of the COVID IP waiver that the U.S. International Trade Commission (USITC) has scheduled March …
IP waiver directly threatens U.S. medical innovation, biomanufacturing Read More »
While animal activists oppose animal testing on moral grounds, the biotech industry knows that alternative technology can provide more accurate and less expensive screening for …
Biotech wants to reduce animal testing and FDA is now tasked with helping Read More »
The importance of data and the growing use of technology – such as wearables and other mobile devices and sensors that can collect and store …
How biotech is addressing sources of bias in studies using real-world evidence Read More »
The makers of more than a dozen prescription drugs covered by Medicare are seeing the first impacts of the Inflation Reduction Act (IRA) passed last …
CMS announces penalties on 27 prescription drugs, draft guidance on price controls Read More »
Biotechnology Innovation Organization (BIO) members Bristol Myers’, Pfizer’s, and AbbVie’s drugs “are likely to be among 10 big-selling medicines subject to U.S. price negotiations for …
U.S. drug price negotiation already affecting Bristol Myers, Pfizer, AbbVie Read More »
America’s largest integrated healthcare system, the Veterans Health Administration (VHA), will be providing coverage of LEQEMBI (lecanemab-irmb) “to veterans living with early stages of Alzheimer’s …
VHA is the first major insurer to cover Alzheimer’s drug LEQEMBI Read More »
In recent years, Artificial Intelligence (AI) has boomed in healthcare. AI is helping scientists obtain relevant data, accurately predict diseases at early stages, and help …
I am BIO Podcast: How AI and biotech can ‘run evolution at hyperspeed’ Read More »
On Friday, March 10, 2023, the United States Food and Drug Administration (FDA) approved Acadia Pharmaceuticals’ drug for genetic Rett syndrome, the company announced in …
FDA approves Acadia’s DAYBUE for the treatment of Rett syndrome Read More »
The 2024 budget proposal President Biden officially released yesterday is facing rocky ground ahead calling for, among other things, more innovation-killing drug price controls under …
Drug price controls in Biden’s proposed budget hurtful for patients, R&D Read More »
